The pattern: nausea returns within days of the dose increase, peaks during the first one to two weeks at the new dose, and improves over the following two to three weeks as your body adapts to the new steady state
PlexusDx Personalized Approach: Better Than Combining Medications The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), and GIPR (rs1800437) variants that relate to GLP-1 and related signaling pathways
Although there were no statistically significant differences between the treatment groups for adverse events, numbers of subjects reporting adverse events, serious adverse events, treatment-related adverse events, and severe adverse events were all greater in the treatment group (Table 12)
Tirzepatide (dual GLP-1/GIP receptor agonist) carries similar concerns about gastric slowing
The steps outlined in this article are just a guideline
Diethylpropion is a sympathomimetic amine and has stimulant-like properties